DK164641C - Anvendelse af acetyl-l-carnitin og farmaologisk acceptable salte deraf til fremstilling af laegemidler til behandling af perifere neuropathier - Google Patents

Anvendelse af acetyl-l-carnitin og farmaologisk acceptable salte deraf til fremstilling af laegemidler til behandling af perifere neuropathier

Info

Publication number
DK164641C
DK164641C DK403587A DK403587A DK164641C DK 164641 C DK164641 C DK 164641C DK 403587 A DK403587 A DK 403587A DK 403587 A DK403587 A DK 403587A DK 164641 C DK164641 C DK 164641C
Authority
DK
Denmark
Prior art keywords
carnitine
acetyl
pharmaceuticals
preparation
treatment
Prior art date
Application number
DK403587A
Other languages
English (en)
Other versions
DK403587D0 (da
DK403587A (da
DK164641B (da
Inventor
Menotti Calvani
Luigi Mosconi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of DK403587D0 publication Critical patent/DK403587D0/da
Publication of DK403587A publication Critical patent/DK403587A/da
Publication of DK164641B publication Critical patent/DK164641B/da
Application granted granted Critical
Publication of DK164641C publication Critical patent/DK164641C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK403587A 1986-08-04 1987-08-03 Anvendelse af acetyl-l-carnitin og farmaologisk acceptable salte deraf til fremstilling af laegemidler til behandling af perifere neuropathier DK164641C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48358/86A IT1196564B (it) 1986-08-04 1986-08-04 Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
IT4835886 1986-08-04

Publications (4)

Publication Number Publication Date
DK403587D0 DK403587D0 (da) 1987-08-03
DK403587A DK403587A (da) 1988-02-05
DK164641B DK164641B (da) 1992-07-27
DK164641C true DK164641C (da) 1992-12-14

Family

ID=11266089

Family Applications (1)

Application Number Title Priority Date Filing Date
DK403587A DK164641C (da) 1986-08-04 1987-08-03 Anvendelse af acetyl-l-carnitin og farmaologisk acceptable salte deraf til fremstilling af laegemidler til behandling af perifere neuropathier

Country Status (11)

Country Link
US (1) US4751242A (da)
EP (1) EP0256999B1 (da)
JP (1) JPH085786B2 (da)
AT (1) ATE70439T1 (da)
CA (1) CA1298197C (da)
DE (1) DE3775301D1 (da)
DK (1) DK164641C (da)
ES (1) ES2039262T3 (da)
GR (1) GR3003405T3 (da)
IT (1) IT1196564B (da)
ZA (1) ZA875643B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
US5641764A (en) * 1989-03-31 1997-06-24 Peter Maccallum Institute Halogenated DNA ligand radiosensitizers for cancer therapy
IT1230141B (it) * 1989-05-03 1991-10-14 Fidia Spa Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JPH11298323A (ja) 1998-04-16 1999-10-29 Nec Yamagata Ltd 高速ロックアップｐｌｌ回路
US20030199535A1 (en) * 1998-07-30 2003-10-23 Claudio Cavazza Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
ES2235499T3 (es) * 1998-07-30 2005-07-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de derivados de propionil l-carnitina y de acetil l-carnitina en la preparacion de medicamentos con actividad anticancerigena.
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
US6562869B1 (en) * 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
AU7828200A (en) * 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
ITRM20010293A1 (it) * 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
ITRM20010294A1 (it) * 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil l-carnetina in associazione con la biotina per il trattamento di pazienti affetti da diabete mellito di tipo ii insulino re
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
ITRM20040327A1 (it) * 2004-07-01 2004-10-01 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
ES2425045T3 (es) * 2005-04-26 2013-10-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Acetil-L-carnitina para la prevención de la neuropatía diabética periférica dolorosa
US20080161604A1 (en) * 2005-04-26 2008-07-03 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Acetyl L-Carnitine For Preventing Painful Peripheral Diabetic Neuropathy
US8569366B2 (en) * 2005-04-26 2013-10-29 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes
JP2006347935A (ja) * 2005-06-15 2006-12-28 Masanori Ogata 炎症性サイトカインの産生が関与する疾患の予防及び／又は治療のための医薬
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
SG185692A1 (en) 2010-06-16 2013-01-30 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
PL3277273T3 (pl) 2015-03-31 2020-11-02 Kolinpharma S.P.A. Kompozycja do leczenia neuropatii i/lub bólu neuropatycznego
US10036011B2 (en) * 2016-02-11 2018-07-31 Qiagen Waltham, Inc. Scavenger compounds for improved sequencing-by-synthesis
US20230181475A1 (en) 2020-05-15 2023-06-15 Alfasigma S.P.A. Composition comprising methylfolate
EP4364730A1 (en) 2022-11-02 2024-05-08 Chiesi Italia S.p.A. Pharmaceutical composition comprising l-acetyl carnitine and beta-caryophyllene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
DK403587D0 (da) 1987-08-03
DK403587A (da) 1988-02-05
ATE70439T1 (de) 1992-01-15
DK164641B (da) 1992-07-27
GR3003405T3 (en) 1993-02-17
CA1298197C (en) 1992-03-31
EP0256999A2 (en) 1988-02-24
ZA875643B (en) 1988-11-30
DE3775301D1 (de) 1992-01-30
JPH085786B2 (ja) 1996-01-24
EP0256999A3 (en) 1989-05-31
US4751242A (en) 1988-06-14
IT8648358A0 (it) 1986-08-04
JPS6344522A (ja) 1988-02-25
IT1196564B (it) 1988-11-16
ES2039262T3 (es) 1993-09-16
EP0256999B1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
DK164641C (da) Anvendelse af acetyl-l-carnitin og farmaologisk acceptable salte deraf til fremstilling af laegemidler til behandling af perifere neuropathier
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
RU93045710A (ru) Противовирусная нуклеозидная композиция, способ ее получения и способ лечения
ATE118216T1 (de) Dopamin-medikament-vorstufe.
RU2059603C1 (ru) ПРОИЗВОДНЫЕ α -ЗАМЕЩЕННЫХ АРИЛУКСУСНЫХ КИСЛОТ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
DK207889D0 (da) Farmaceutisk praeparat med anti-cancer virkning
DE69222698T2 (de) 4-desoxy-4-epipodophyllotoxinderivate oder deren pharmazeutisch akzeptierbaren salze
ATE97001T1 (de) Topisch anzuwendende defibrotid enthaltende arzneizubereitungen.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
IT1224250B (it) Associzione del depiprazolo con la morfina
DE59501945D1 (de) Orale Arzeimittelzubereitung enthaltend Diclofenac-Natrium und eine organische Säure
DK447387A (da) Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DE3677319D1 (de) Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung.
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
KR930019207A (ko) 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도
SE8800018D0 (sv) Farmaceutiskt aktiva salter
RU92013625A (ru) Лекарственное средство, стимулирующее эритроидный росток кроветворения при цитостатических миелодепрессиях
RU93058142A (ru) Производные хинолина, способ их получения, фармацевтическая композиция и способ лечения
RU97109158A (ru) Способ предоперационного лечения больных раком яичников iii - iv стадии
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
TH23739B (th) สารละลายลูบิลูโซลสำหรับการให้ทางหลอดเลือดดำ
ATE56144T1 (de) Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt.

Legal Events

Date Code Title Description
PUP Patent expired